Rasika Vartak

Rasika Vartak

Auto-generated profile, based on publicly available information

Rasika Vartak

Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
BWBelinda Wang
Belinda Wang
RVRasika Vartak
Rasika Vartak
YZYefim Zaltsman
Yefim Zaltsman
ZNZun Zar Chi Naing
Zun Zar Chi Naing
KHKelsey M. Hennick
Kelsey M. Hennick
NKNevan J. Krogan
Nevan J. Krogan
Summary: Translating high-confidence (hc) autism spectrum disorder (ASD) genes into viable treatment targets remains elusive. We constructed a foundational protein-protein interaction (PPI) network in HEK293T cells involving 100 hcASD risk genes, revealing over 1,800 PPIs (87% novel). Interactors, expressed in the human brain and enriched for ASD but not schizophrenia genetic risk, converged on protein complexes involved in neurogenesis, tubulin biology, transcriptional regulation, and chromatin modification. A PPI map of 54 patient-derived missense variants identified differential physical interactions, and we leveraged AlphaFold-Multimer predictions to prioritize direct PPIs and specific variants for interrogation in Xenopus tropicalis and human forebrain organoids. A mutation in the transcription factor FOXP1 led to reconfiguration of DNA binding sites and altered development of deep cortical layer neurons in forebrain organoids. This work offers new insights into molecular mechanisms underlying ASD and describes a powerful platform to develop and test therapeutic strategies for many genetically-defined conditions.

27 August 2026 in Science
Verified
Journal Article
Closed access
BWBelinda Wang
Belinda Wang
RVRasika Vartak
Rasika Vartak
KHKelsey M. Hennick
Kelsey M. Hennick
YZYefim Zaltsman
Yefim Zaltsman
ZNZun Zar Chi Naing
Zun Zar Chi Naing
NKNevan J. Krogan
Nevan J. Krogan
Systematic mapping of protein-protein interaction (PPI) networks and determining how causal mutations rewire them in autism spectrum disorder (ASD) provide a powerful framework for uncovering disease mechanisms and therapeutic opportunities. Using affinity purification–mass spectrometry, we systematically mapped PPIs for 100 high-confidence ASD genes, uncovering more than 1800 interactions. By assessing the impact of pathogenic missense mutations, leveraging AlphaFold, and validating key findings in human-derived model systems, we identified marked convergence onto shared protein complexes in the wild-type state and convergent PPI rewiring driven by independent mutations. For example, distinct patient-derived variants in FOXP1 disrupt its interactions with FOXP4, leading to changes in cortical neurogenesis and neural activity in brain organoids. Overall, these findings link genetic variation to protein networks and convergent neurodevelopmental dysfunction in ASD.